Trial Profile
Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Interleukin-7 (Primary)
- Indications Idiopathic CD4-positive T-lymphocytopenia
- Focus Adverse reactions
- Acronyms ICICLE
- 16 Dec 2015 Results published in the Blood
- 15 Jan 2015 New trial record